| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein domain specific binding | 6.34e-06 | 875 | 40 | 10 | GO:0019904 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.28e-05 | 23 | 40 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | synaptic receptor adaptor activity | 2.34e-05 | 4 | 40 | 2 | GO:0030160 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 1.72e-04 | 54 | 40 | 3 | GO:0030159 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.82e-04 | 55 | 40 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.89e-04 | 143 | 40 | 4 | GO:0017124 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 2.13e-04 | 11 | 40 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 2.35e-04 | 60 | 40 | 3 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 2.47e-04 | 61 | 40 | 3 | GO:0098531 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 3.01e-04 | 13 | 40 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 3.01e-04 | 13 | 40 | 2 | GO:0098879 | |
| GeneOntologyMolecularFunction | transcription factor binding | 6.63e-04 | 753 | 40 | 7 | GO:0008134 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.40e-03 | 417 | 40 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.84e-03 | 1160 | 40 | 8 | GO:0030674 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.87e-03 | 32 | 40 | 2 | GO:0099186 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 2.19e-03 | 129 | 40 | 3 | GO:0035591 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 3.20e-03 | 42 | 40 | 2 | GO:0098918 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.30e-03 | 739 | 40 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.51e-03 | 44 | 40 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 4.83e-03 | 1356 | 40 | 8 | GO:0060090 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 4.87e-03 | 52 | 40 | 2 | GO:0035255 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 5.86e-03 | 582 | 40 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 6.03e-03 | 58 | 40 | 2 | GO:0051018 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 6.19e-03 | 187 | 40 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | protein kinase binding | 7.39e-03 | 873 | 40 | 6 | GO:0019901 | |
| GeneOntologyMolecularFunction | zinc ion binding | 8.14e-03 | 891 | 40 | 6 | GO:0008270 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 8.20e-03 | 68 | 40 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 8.43e-03 | 69 | 40 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 8.91e-03 | 71 | 40 | 2 | GO:0042054 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 4.56e-07 | 249 | 40 | 7 | GO:0035264 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell differentiation | 6.41e-06 | 19 | 40 | 3 | GO:0055012 | |
| GeneOntologyBiologicalProcess | developmental growth | 6.81e-06 | 911 | 40 | 10 | GO:0048589 | |
| GeneOntologyBiologicalProcess | head development | 7.35e-06 | 919 | 40 | 10 | GO:0060322 | |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 2.38e-05 | 29 | 40 | 3 | GO:0003417 | |
| GeneOntologyBiologicalProcess | brain development | 3.09e-05 | 859 | 40 | 9 | GO:0007420 | |
| GeneOntologyBiologicalProcess | embryonic hindlimb morphogenesis | 4.24e-05 | 35 | 40 | 3 | GO:0035116 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 4.61e-05 | 36 | 40 | 3 | GO:0061037 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 5.44e-05 | 38 | 40 | 3 | GO:0048384 | |
| GeneOntologyBiologicalProcess | endochondral bone growth | 5.88e-05 | 39 | 40 | 3 | GO:0003416 | |
| GeneOntologyBiologicalProcess | limb development | 6.97e-05 | 224 | 40 | 5 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 6.97e-05 | 224 | 40 | 5 | GO:0048736 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell development | 7.90e-05 | 43 | 40 | 3 | GO:0002068 | |
| GeneOntologyBiologicalProcess | bone growth | 9.06e-05 | 45 | 40 | 3 | GO:0098868 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 9.06e-05 | 45 | 40 | 3 | GO:0031076 | |
| GeneOntologyBiologicalProcess | growth | 9.28e-05 | 1235 | 40 | 10 | GO:0040007 | |
| GeneOntologyBiologicalProcess | trachea cartilage development | 1.02e-04 | 8 | 40 | 2 | GO:0060534 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 1.03e-04 | 47 | 40 | 3 | GO:0060351 | |
| GeneOntologyBiologicalProcess | hindlimb morphogenesis | 1.17e-04 | 49 | 40 | 3 | GO:0035137 | |
| GeneOntologyBiologicalProcess | positive regulation of early endosome to late endosome transport | 1.31e-04 | 9 | 40 | 2 | GO:2000643 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic density structure | 1.31e-04 | 9 | 40 | 2 | GO:0099562 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 1.65e-04 | 269 | 40 | 5 | GO:0002064 | |
| GeneOntologyBiologicalProcess | cell junction maintenance | 2.72e-04 | 65 | 40 | 3 | GO:0034331 | |
| GeneOntologyBiologicalProcess | regulation of myelination | 2.97e-04 | 67 | 40 | 3 | GO:0031641 | |
| GeneOntologyBiologicalProcess | embryo development | 3.21e-04 | 1437 | 40 | 10 | GO:0009790 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell development | 3.24e-04 | 69 | 40 | 3 | GO:0002066 | |
| GeneOntologyBiologicalProcess | forebrain development | 3.33e-04 | 489 | 40 | 6 | GO:0030900 | |
| GeneOntologyBiologicalProcess | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 3.79e-04 | 15 | 40 | 2 | GO:0043328 | |
| GeneOntologyBiologicalProcess | central nervous system development | 3.86e-04 | 1197 | 40 | 9 | GO:0007417 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 4.21e-04 | 1211 | 40 | 9 | GO:0030334 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 4.82e-04 | 79 | 40 | 3 | GO:0060350 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic specialization structure | 4.90e-04 | 17 | 40 | 2 | GO:0098880 | |
| GeneOntologyBiologicalProcess | regulation of cartilage development | 5.19e-04 | 81 | 40 | 3 | GO:0061035 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 5.98e-04 | 85 | 40 | 3 | GO:1903670 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 6.30e-04 | 1280 | 40 | 9 | GO:2000145 | |
| GeneOntologyBiologicalProcess | gland development | 6.70e-04 | 558 | 40 | 6 | GO:0048732 | |
| GeneOntologyBiologicalProcess | regulation of early endosome to late endosome transport | 6.82e-04 | 20 | 40 | 2 | GO:2000641 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 6.89e-04 | 561 | 40 | 6 | GO:0048568 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell differentiation | 7.29e-04 | 91 | 40 | 3 | GO:0002067 | |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 7.77e-04 | 93 | 40 | 3 | GO:0040014 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 8.03e-04 | 1053 | 40 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 8.16e-04 | 1327 | 40 | 9 | GO:0040012 | |
| GeneOntologyBiologicalProcess | trachea development | 8.27e-04 | 22 | 40 | 2 | GO:0060438 | |
| GeneOntologyBiologicalProcess | regulation of cell size | 9.26e-04 | 225 | 40 | 4 | GO:0008361 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 9.85e-04 | 24 | 40 | 2 | GO:0071625 | |
| GeneOntologyBiologicalProcess | cellular component maintenance | 9.87e-04 | 101 | 40 | 3 | GO:0043954 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport via multivesicular body sorting pathway | 1.25e-03 | 27 | 40 | 2 | GO:0032511 | |
| GeneOntologyBiologicalProcess | negative regulation of chondrocyte differentiation | 1.25e-03 | 27 | 40 | 2 | GO:0032331 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 1.26e-03 | 421 | 40 | 5 | GO:0048638 | |
| GeneOntologyBiologicalProcess | female pregnancy | 1.35e-03 | 249 | 40 | 4 | GO:0007565 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 1.62e-03 | 906 | 40 | 7 | GO:0043009 | |
| GeneOntologyBiologicalProcess | hypothalamus development | 1.65e-03 | 31 | 40 | 2 | GO:0021854 | |
| GeneOntologyBiologicalProcess | bone development | 1.67e-03 | 264 | 40 | 4 | GO:0060348 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron differentiation | 1.74e-03 | 123 | 40 | 3 | GO:0045666 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell proliferation | 1.75e-03 | 32 | 40 | 2 | GO:2000647 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 1.78e-03 | 124 | 40 | 3 | GO:0060349 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.80e-03 | 1194 | 40 | 8 | GO:0000902 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.86e-03 | 929 | 40 | 7 | GO:0009792 | |
| GeneOntologyBiologicalProcess | positive regulation of sprouting angiogenesis | 1.86e-03 | 33 | 40 | 2 | GO:1903672 | |
| GeneOntologyBiologicalProcess | centrosome localization | 2.10e-03 | 35 | 40 | 2 | GO:0051642 | |
| GeneOntologyBiologicalProcess | embryonic digestive tract development | 2.10e-03 | 35 | 40 | 2 | GO:0048566 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 2.22e-03 | 36 | 40 | 2 | GO:0061842 | |
| GeneOntologyBiologicalProcess | eye development | 2.25e-03 | 480 | 40 | 5 | GO:0001654 | |
| GeneOntologyBiologicalProcess | axon extension | 2.27e-03 | 135 | 40 | 3 | GO:0048675 | |
| GeneOntologyBiologicalProcess | visual system development | 2.31e-03 | 483 | 40 | 5 | GO:0150063 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 2.34e-03 | 37 | 40 | 2 | GO:0043162 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 2.35e-03 | 290 | 40 | 4 | GO:0044703 | |
| GeneOntologyBiologicalProcess | embryonic eye morphogenesis | 2.47e-03 | 38 | 40 | 2 | GO:0048048 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 2.47e-03 | 294 | 40 | 4 | GO:0044706 | |
| GeneOntologyBiologicalProcess | sensory system development | 2.48e-03 | 491 | 40 | 5 | GO:0048880 | |
| GeneOntologyBiologicalProcess | limbic system development | 2.57e-03 | 141 | 40 | 3 | GO:0021761 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport | 2.60e-03 | 39 | 40 | 2 | GO:0045324 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 2.62e-03 | 299 | 40 | 4 | GO:0060560 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 2.69e-03 | 301 | 40 | 4 | GO:0048588 | |
| GeneOntologyBiologicalProcess | maintenance of synapse structure | 2.73e-03 | 40 | 40 | 2 | GO:0099558 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 2.94e-03 | 148 | 40 | 3 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 2.94e-03 | 148 | 40 | 3 | GO:0035113 | |
| GeneOntologyBiologicalProcess | maintenance of blood-brain barrier | 3.01e-03 | 42 | 40 | 2 | GO:0035633 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 3.09e-03 | 313 | 40 | 4 | GO:0099173 | |
| GeneOntologyBiologicalProcess | endosome transport via multivesicular body sorting pathway | 3.15e-03 | 43 | 40 | 2 | GO:0032509 | |
| MousePheno | fusion of atlas and odontoid process | 1.42e-06 | 10 | 33 | 3 | MP:0010701 | |
| MousePheno | absent metoptic pillar | 5.40e-06 | 2 | 33 | 2 | MP:0010705 | |
| MousePheno | abnormal odontoid process morphology | 9.55e-06 | 18 | 33 | 3 | MP:0004659 | |
| MousePheno | split cervical atlas | 3.23e-05 | 4 | 33 | 2 | MP:0010702 | |
| MousePheno | split cervical axis | 3.23e-05 | 4 | 33 | 2 | MP:0010703 | |
| MousePheno | abnormal optic canal morphology | 5.38e-05 | 5 | 33 | 2 | MP:0010704 | |
| MousePheno | abnormal cervical axis morphology | 6.82e-05 | 34 | 33 | 3 | MP:0004608 | |
| MousePheno | decreased total retina thickness | 9.10e-05 | 197 | 33 | 5 | MP:0011965 | |
| MousePheno | cervical vertebral transformation | 1.20e-04 | 41 | 33 | 3 | MP:0004615 | |
| MousePheno | cervical vertebral fusion | 1.29e-04 | 42 | 33 | 3 | MP:0004620 | |
| MousePheno | abnormal orbitosphenoid bone morphology | 1.50e-04 | 8 | 33 | 2 | MP:0004457 | |
| MousePheno | abnormal total retina thickness | 1.63e-04 | 223 | 33 | 5 | MP:0011963 | |
| MousePheno | narrow eye opening | 2.18e-04 | 50 | 33 | 3 | MP:0005287 | |
| MousePheno | abnormal cervical atlas morphology | 2.31e-04 | 51 | 33 | 3 | MP:0004607 | |
| MousePheno | decreased gonadotroph cell number | 2.93e-04 | 11 | 33 | 2 | MP:0008335 | |
| MousePheno | abnormal eyelid aperture | 3.56e-04 | 59 | 33 | 3 | MP:0003671 | |
| MousePheno | fusion of vertebral arches | 3.93e-04 | 61 | 33 | 3 | MP:0004613 | |
| MousePheno | fusion of atlas and occipital bones | 4.15e-04 | 13 | 33 | 2 | MP:0010728 | |
| MousePheno | abnormal cricoid cartilage morphology | 5.57e-04 | 15 | 33 | 2 | MP:0002258 | |
| MousePheno | abnormal gonadotroph morphology | 5.57e-04 | 15 | 33 | 2 | MP:0008325 | |
| MousePheno | decreased mature ovarian follicle number | 6.66e-04 | 73 | 33 | 3 | MP:0002682 | |
| MousePheno | failure of superovulation | 8.08e-04 | 18 | 33 | 2 | MP:0031422 | |
| MousePheno | abnormal orbit morphology | 8.08e-04 | 18 | 33 | 2 | MP:0010030 | |
| MousePheno | abnormal lens development | 8.08e-04 | 78 | 33 | 3 | MP:0005545 | |
| MousePheno | abnormal mature ovarian follicle morphology | 8.08e-04 | 78 | 33 | 3 | MP:0009364 | |
| MousePheno | abnormal long-term depression | 9.35e-04 | 82 | 33 | 3 | MP:0001898 | |
| MousePheno | increased cholesterol level | 1.01e-03 | 502 | 33 | 6 | MP:0003982 | |
| MousePheno | abnormal lens morphology | 1.04e-03 | 699 | 33 | 7 | MP:0001303 | |
| MousePheno | increased sterol level | 1.04e-03 | 505 | 33 | 6 | MP:0012226 | |
| Domain | Retinoic_acid_rcpt | 3.63e-08 | 4 | 40 | 3 | IPR003078 | |
| Domain | WBP1-like | 2.68e-05 | 4 | 40 | 2 | IPR021684 | |
| Domain | WBP-1 | 2.68e-05 | 4 | 40 | 2 | PF11669 | |
| Domain | AWS | 4.45e-05 | 5 | 40 | 2 | PS51215 | |
| Domain | AWS_dom | 4.45e-05 | 5 | 40 | 2 | IPR006560 | |
| Domain | AWS | 4.45e-05 | 5 | 40 | 2 | SM00570 | |
| Domain | zf-C4 | 1.30e-04 | 46 | 40 | 3 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 1.30e-04 | 46 | 40 | 3 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 1.30e-04 | 46 | 40 | 3 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 1.30e-04 | 46 | 40 | 3 | IPR001723 | |
| Domain | ZnF_C4 | 1.30e-04 | 46 | 40 | 3 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 1.30e-04 | 46 | 40 | 3 | PS51030 | |
| Domain | - | 1.38e-04 | 47 | 40 | 3 | 1.10.565.10 | |
| Domain | HOLI | 1.47e-04 | 48 | 40 | 3 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 1.47e-04 | 48 | 40 | 3 | IPR000536 | |
| Domain | Hormone_recep | 1.47e-04 | 48 | 40 | 3 | PF00104 | |
| Domain | - | 2.46e-04 | 57 | 40 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 2.59e-04 | 58 | 40 | 3 | IPR013088 | |
| Domain | OAR | 4.61e-04 | 15 | 40 | 2 | PF03826 | |
| Domain | OAR | 5.27e-04 | 16 | 40 | 2 | PS50803 | |
| Domain | Post-SET_dom | 5.27e-04 | 16 | 40 | 2 | IPR003616 | |
| Domain | PostSET | 5.27e-04 | 16 | 40 | 2 | SM00508 | |
| Domain | OAR_dom | 5.27e-04 | 16 | 40 | 2 | IPR003654 | |
| Domain | POST_SET | 5.27e-04 | 16 | 40 | 2 | PS50868 | |
| Domain | SH3_2 | 8.23e-04 | 86 | 40 | 3 | IPR011511 | |
| Domain | SH3_2 | 8.23e-04 | 86 | 40 | 3 | PF07653 | |
| Domain | - | 3.15e-03 | 39 | 40 | 2 | 3.30.1370.10 | |
| Domain | PDZ | 3.39e-03 | 141 | 40 | 3 | PF00595 | |
| Domain | SET | 3.48e-03 | 41 | 40 | 2 | PF00856 | |
| Domain | Znf_FYVE_PHD | 3.81e-03 | 147 | 40 | 3 | IPR011011 | |
| Domain | PDZ | 3.89e-03 | 148 | 40 | 3 | SM00228 | |
| Domain | KH_dom_type_1 | 4.00e-03 | 44 | 40 | 2 | IPR004088 | |
| Domain | - | 4.04e-03 | 150 | 40 | 3 | 2.30.42.10 | |
| Domain | PDZ | 4.11e-03 | 151 | 40 | 3 | PS50106 | |
| Domain | PDZ | 4.19e-03 | 152 | 40 | 3 | IPR001478 | |
| Domain | SET | 4.36e-03 | 46 | 40 | 2 | SM00317 | |
| Domain | SET_dom | 5.13e-03 | 50 | 40 | 2 | IPR001214 | |
| Domain | SET | 5.13e-03 | 50 | 40 | 2 | PS50280 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 1.25e-07 | 6 | 27 | 3 | M48097 | |
| Pathway | PID_RXR_VDR_PATHWAY | 1.58e-05 | 26 | 27 | 3 | M162 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.46e-05 | 30 | 27 | 3 | M207 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 2.46e-05 | 30 | 27 | 3 | MM15866 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 3.29e-05 | 33 | 27 | 3 | MM1448 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 3.60e-05 | 34 | 27 | 3 | M16393 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 3.94e-05 | 35 | 27 | 3 | M39488 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 5.05e-05 | 38 | 27 | 3 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 5.05e-05 | 38 | 27 | 3 | MM15865 | |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 7.35e-05 | 43 | 27 | 3 | M39554 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 7.35e-05 | 43 | 27 | 3 | M27443 | |
| Pathway | WP_RETINOL_METABOLISM | 7.88e-05 | 44 | 27 | 3 | MM15851 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.02e-04 | 48 | 27 | 3 | MM14987 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.09e-04 | 49 | 27 | 3 | MM15186 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.38e-04 | 53 | 27 | 3 | M8276 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 1.99e-04 | 60 | 27 | 3 | M40048 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 9.64e-04 | 1432 | 27 | 9 | M509 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.59e-03 | 122 | 27 | 3 | M29689 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.80e-03 | 33 | 27 | 2 | M39875 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.80e-03 | 33 | 27 | 2 | M39503 | |
| Pubmed | 3.13e-10 | 10 | 40 | 4 | 18539269 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 7607068 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 7607067 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 11172439 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 8383767 | ||
| Pubmed | Retinoic acid receptor gamma: specific immunodetection and phosphorylation. | 1.41e-09 | 3 | 40 | 3 | 1655807 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 17252005 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 8626453 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 8388780 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 9659935 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 7910825 | ||
| Pubmed | Tissue-specific expression of retinoic acid receptor isoform transcripts in the mouse embryo. | 1.41e-09 | 3 | 40 | 3 | 10842077 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 10100049 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 9699718 | ||
| Pubmed | Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. | 1.41e-09 | 3 | 40 | 3 | 1283441 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 36446525 | ||
| Pubmed | Association of retinoic acid receptor genes with meningomyelocele. | 1.41e-09 | 3 | 40 | 3 | 21254357 | |
| Pubmed | Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes. | 1.41e-09 | 3 | 40 | 3 | 1655630 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 9852056 | ||
| Pubmed | The molecular and genetic dissection of the retinoid signalling pathway. | 1.41e-09 | 3 | 40 | 3 | 8276261 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 15831518 | ||
| Pubmed | Immunolocalization of retinoic acid receptors in rat, mouse and human ovary and uterus. | 1.41e-09 | 3 | 40 | 3 | 8136307 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 24357724 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 8027572 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 2544807 | ||
| Pubmed | [Genetic expression and morphogenesis of the skin in vertebrates]. | 1.41e-09 | 3 | 40 | 3 | 8099268 | |
| Pubmed | Specificity of retinoid receptor gene expression in mouse cervical epithelia. | 1.41e-09 | 3 | 40 | 3 | 8156902 | |
| Pubmed | Characterization of retinoic acid receptor-deficient keratinocytes. | 1.41e-09 | 3 | 40 | 3 | 10748128 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 2737701 | ||
| Pubmed | Immunohistochemical localization of the retinoic Acid receptors in human prostate. | 1.41e-09 | 3 | 40 | 3 | 12399530 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 29848550 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 19350571 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 24050824 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 7626396 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 17363914 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 12093741 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 14691372 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 18845237 | ||
| Pubmed | The retinoic acid receptors RARalpha and RARgamma are required for inner ear development. | 5.63e-09 | 4 | 40 | 3 | 12464434 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 9376317 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 2556642 | ||
| Pubmed | Retinoic acid signalling in the development of branchial arches. | 5.63e-09 | 4 | 40 | 3 | 15380252 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 10869350 | ||
| Pubmed | 1.01e-08 | 549 | 40 | 9 | 38280479 | ||
| Pubmed | SHANK1 RNF38 EZR JCAD RARB DAZAP1 NRCAM TJP1 PPRC1 ZMYM4 ZBTB4 ASH1L | 1.32e-08 | 1285 | 40 | 12 | 35914814 | |
| Pubmed | Retinoic acid signaling regulates murine bronchial tubule formation. | 1.41e-08 | 5 | 40 | 3 | 12834868 | |
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 19665987 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 9053308 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 8174226 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 8152920 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 1334737 | ||
| Pubmed | High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. | 1.41e-08 | 5 | 40 | 3 | 8394014 | |
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 9097025 | ||
| Pubmed | Retinal dysplasia and degeneration in RARbeta2/RARgamma2 compound mutant mice. | 1.41e-08 | 5 | 40 | 3 | 8681798 | |
| Pubmed | Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. | 1.41e-08 | 5 | 40 | 3 | 19006694 | |
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 19345331 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.78e-08 | 430 | 40 | 8 | 35044719 | |
| Pubmed | Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes. | 2.81e-08 | 6 | 40 | 3 | 11328745 | |
| Pubmed | 2.81e-08 | 6 | 40 | 3 | 9153406 | ||
| Pubmed | Roles of retinoic acid receptors in early embryonic morphogenesis and hindbrain patterning. | 2.81e-08 | 6 | 40 | 3 | 11493525 | |
| Pubmed | Spatial distributions of retinoic acid receptor gene transcripts in the prenatal mouse inner ear. | 2.81e-08 | 6 | 40 | 3 | 9548551 | |
| Pubmed | Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis. | 2.81e-08 | 6 | 40 | 3 | 9464546 | |
| Pubmed | Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid. | 2.81e-08 | 6 | 40 | 3 | 20557428 | |
| Pubmed | 2.81e-08 | 6 | 40 | 3 | 8801169 | ||
| Pubmed | 2.81e-08 | 6 | 40 | 3 | 8801176 | ||
| Pubmed | The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. | 2.81e-08 | 6 | 40 | 3 | 9806918 | |
| Pubmed | 2.81e-08 | 6 | 40 | 3 | 1966045 | ||
| Pubmed | A genetic dissection of the retinoid signalling pathway in the mouse. | 2.81e-08 | 6 | 40 | 3 | 10604193 | |
| Pubmed | 2.81e-08 | 6 | 40 | 3 | 1849812 | ||
| Pubmed | 2.81e-08 | 6 | 40 | 3 | 9590554 | ||
| Pubmed | 2.81e-08 | 6 | 40 | 3 | 9075714 | ||
| Pubmed | Dissecting the role of retinoic acid receptor isoforms in the CD8 response to infection. | 4.92e-08 | 7 | 40 | 3 | 24610012 | |
| Pubmed | 4.92e-08 | 7 | 40 | 3 | 12665583 | ||
| Pubmed | Retinoic acid signaling is dispensable for somatic development and function in the mammalian ovary. | 4.92e-08 | 7 | 40 | 3 | 28274610 | |
| Pubmed | Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha. | 4.92e-08 | 7 | 40 | 3 | 11493527 | |
| Pubmed | 4.92e-08 | 7 | 40 | 3 | 8397079 | ||
| Pubmed | Role of the retinoic acid receptor beta (RARbeta) during mouse development. | 4.92e-08 | 7 | 40 | 3 | 9240560 | |
| Pubmed | 4.92e-08 | 7 | 40 | 3 | 12360493 | ||
| Pubmed | 4.92e-08 | 7 | 40 | 3 | 17195188 | ||
| Pubmed | Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways. | 4.92e-08 | 7 | 40 | 3 | 10684250 | |
| Pubmed | 4.92e-08 | 7 | 40 | 3 | 15635645 | ||
| Pubmed | 4.92e-08 | 7 | 40 | 3 | 8090775 | ||
| Pubmed | 7.65e-08 | 35 | 40 | 4 | 19389355 | ||
| Pubmed | Retinoic acid receptors exhibit cell-autonomous functions in cranial neural crest cells. | 7.86e-08 | 8 | 40 | 3 | 19777591 | |
| Pubmed | Expression of nuclear retinoic acid receptors during mouse odontogenesis. | 7.86e-08 | 8 | 40 | 3 | 7988794 | |
| Pubmed | Retinoids and adipose tissues: metabolism, cell differentiation and gene expression. | 7.86e-08 | 8 | 40 | 3 | 10094571 | |
| Pubmed | Prepubertal testis development relies on retinoic acid but not rexinoid receptors in Sertoli cells. | 7.86e-08 | 8 | 40 | 3 | 17124491 | |
| Pubmed | 1.18e-07 | 9 | 40 | 3 | 8555112 | ||
| Pubmed | 1.18e-07 | 9 | 40 | 3 | 16574820 | ||
| Pubmed | 1.18e-07 | 9 | 40 | 3 | 21722948 | ||
| Pubmed | 1.68e-07 | 10 | 40 | 3 | 17363140 | ||
| Pubmed | 2.31e-07 | 11 | 40 | 3 | 29093497 | ||
| Pubmed | Reduced BMP4 abundance in Gata2 hypomorphic mutant mice result in uropathies resembling human CAKUT. | 2.31e-07 | 11 | 40 | 3 | 18233958 | |
| Pubmed | 3.08e-07 | 12 | 40 | 3 | 1377062 | ||
| Pubmed | 3.08e-07 | 12 | 40 | 3 | 30166332 | ||
| Pubmed | 3.08e-07 | 12 | 40 | 3 | 9022057 | ||
| Pubmed | Mapping of the mouse Rar loci encoding retinoic acid receptors RAR alpha, RAR beta and RAR gamma. | 3.08e-07 | 12 | 40 | 3 | 8251184 | |
| Pubmed | 3.08e-07 | 12 | 40 | 3 | 26427057 | ||
| Pubmed | Isolation and developmental expression of retinoic-acid-induced genes. | 3.08e-07 | 12 | 40 | 3 | 8314004 | |
| Pubmed | 4.00e-07 | 13 | 40 | 3 | 29986869 | ||
| Interaction | WWOX interactions | 2.97e-06 | 627 | 40 | 9 | int:WWOX | |
| Interaction | YAP1 interactions | 6.24e-06 | 1095 | 40 | 11 | int:YAP1 | |
| Interaction | BICD1 interactions | 9.25e-06 | 250 | 40 | 6 | int:BICD1 | |
| Interaction | NCOA1 interactions | 9.99e-06 | 146 | 40 | 5 | int:NCOA1 | |
| Interaction | NCOR2 interactions | 1.26e-05 | 264 | 40 | 6 | int:NCOR2 | |
| Interaction | ITGB1BP2 interactions | 1.62e-05 | 25 | 40 | 3 | int:ITGB1BP2 | |
| Interaction | AP2A1 interactions | 2.55e-05 | 299 | 40 | 6 | int:AP2A1 | |
| Interaction | HACE1 interactions | 2.55e-05 | 29 | 40 | 3 | int:HACE1 | |
| Interaction | RUNX1 interactions | 3.99e-05 | 324 | 40 | 6 | int:RUNX1 | |
| Interaction | OCLN interactions | 5.09e-05 | 500 | 40 | 7 | int:OCLN | |
| Interaction | KRTAP7-1 interactions | 5.82e-05 | 38 | 40 | 3 | int:KRTAP7-1 | |
| Interaction | H2AZ1 interactions | 8.45e-05 | 371 | 40 | 6 | int:H2AZ1 | |
| Interaction | NEDD4 interactions | 8.64e-05 | 544 | 40 | 7 | int:NEDD4 | |
| Interaction | KHDRBS1 interactions | 8.71e-05 | 373 | 40 | 6 | int:KHDRBS1 | |
| Interaction | RARB interactions | 1.04e-04 | 46 | 40 | 3 | int:RARB | |
| Interaction | DNMBP interactions | 1.05e-04 | 124 | 40 | 4 | int:DNMBP | |
| Interaction | RXRG interactions | 1.11e-04 | 47 | 40 | 3 | int:RXRG | |
| Interaction | WWTR1 interactions | 1.71e-04 | 422 | 40 | 6 | int:WWTR1 | |
| Interaction | CEP135 interactions | 1.93e-04 | 272 | 40 | 5 | int:CEP135 | |
| Interaction | ARID1A interactions | 2.07e-04 | 276 | 40 | 5 | int:ARID1A | |
| Interaction | RHOB interactions | 2.07e-04 | 840 | 40 | 8 | int:RHOB | |
| Interaction | RARG interactions | 2.07e-04 | 58 | 40 | 3 | int:RARG | |
| Interaction | S100A3 interactions | 2.18e-04 | 59 | 40 | 3 | int:S100A3 | |
| Interaction | VASP interactions | 2.77e-04 | 294 | 40 | 5 | int:VASP | |
| Interaction | SSTR2 interactions | 2.95e-04 | 13 | 40 | 2 | int:SSTR2 | |
| Interaction | RXRB interactions | 3.04e-04 | 66 | 40 | 3 | int:RXRB | |
| Interaction | RXRA interactions | 3.45e-04 | 169 | 40 | 4 | int:RXRA | |
| Interaction | SH3D19 interactions | 3.47e-04 | 69 | 40 | 3 | int:SH3D19 | |
| Interaction | ZDHHC23 interactions | 4.26e-04 | 74 | 40 | 3 | int:ZDHHC23 | |
| Interaction | DZIP3 interactions | 4.66e-04 | 183 | 40 | 4 | int:DZIP3 | |
| Interaction | PFN1 interactions | 4.66e-04 | 509 | 40 | 6 | int:PFN1 | |
| Interaction | ENTR1 interactions | 5.16e-04 | 188 | 40 | 4 | int:ENTR1 | |
| Cytoband | 1q22 | 1.15e-03 | 57 | 40 | 2 | 1q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q22 | 1.77e-03 | 71 | 40 | 2 | chr1q22 | |
| GeneFamily | Nuclear hormone receptors | 5.84e-05 | 49 | 28 | 3 | 71 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.26e-03 | 34 | 28 | 2 | 487 | |
| GeneFamily | PDZ domain containing | 1.64e-03 | 152 | 28 | 3 | 1220 | |
| GeneFamily | Sterile alpha motif domain containing | 8.15e-03 | 88 | 28 | 2 | 760 | |
| GeneFamily | PHD finger proteins | 8.52e-03 | 90 | 28 | 2 | 88 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 8.88e-03 | 92 | 28 | 2 | 521 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 7.21e-07 | 338 | 40 | 7 | M17094 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.52e-07 | 138 | 40 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 156 | 40 | 4 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 162 | 40 | 4 | 3a1cbfed5a063131d49e3c1584f62b12660ecb36 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 162 | 40 | 4 | 04b3c38bb27fa369a9ac5b60883f8b058abc5180 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 173 | 40 | 4 | 807183fc23478da9451906dacd88de4e73112e0d | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 173 | 40 | 4 | 2e683ec555dc0036875e0f5674dcc5e93ead205d | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.94e-05 | 178 | 40 | 4 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 186 | 40 | 4 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.35e-05 | 187 | 40 | 4 | e9aa0a5a0f8e2593de63e83b56b53ae33e60af49 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.35e-05 | 187 | 40 | 4 | 61b8a53f29bb8b33c69f680b8359a1143a23999d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-05 | 188 | 40 | 4 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 2.45e-05 | 189 | 40 | 4 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 191 | 40 | 4 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 191 | 40 | 4 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.77e-05 | 195 | 40 | 4 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.77e-05 | 195 | 40 | 4 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 195 | 40 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 197 | 40 | 4 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.88e-05 | 197 | 40 | 4 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.94e-05 | 198 | 40 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.05e-05 | 200 | 40 | 4 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.05e-05 | 200 | 40 | 4 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.05e-05 | 200 | 40 | 4 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.05e-05 | 200 | 40 | 4 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.05e-05 | 200 | 40 | 4 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.05e-05 | 200 | 40 | 4 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.05e-05 | 200 | 40 | 4 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.74e-04 | 121 | 40 | 3 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Neuronal-Interneuron|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-04 | 125 | 40 | 3 | eafc39072467e209c9fe3a4fa41cb09507a42e82 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.97e-04 | 145 | 40 | 3 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-04 | 154 | 40 | 3 | 1e088b0d4a44267f46a9b643f46a1aba784686b1 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 156 | 40 | 3 | 28c4fb4d2c6c47696c3a6722998f9da5a8923323 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-04 | 160 | 40 | 3 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 160 | 40 | 3 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 160 | 40 | 3 | 822adcf5f9208f305cafffd8ed97f3a061e82b03 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.03e-04 | 161 | 40 | 3 | 048b7dc00746987a24bf870d4d278c4183eb04a2 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-04 | 162 | 40 | 3 | 76e289ad9fd3694f77fd0d19e74c1cb8e87b8094 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 165 | 40 | 3 | ab6ed7e30096c418e7be2d5eec33feeddd1387d9 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.33e-04 | 165 | 40 | 3 | 94a5211072464fc24592bb107a853ce832e816fe | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.49e-04 | 167 | 40 | 3 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.49e-04 | 167 | 40 | 3 | 25af48c640e67848594f5902867ba325fc105da4 | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.56e-04 | 168 | 40 | 3 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.64e-04 | 169 | 40 | 3 | f086b50791e1c93e253eb5e8d6c4bf617b1416c3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.72e-04 | 170 | 40 | 3 | 5de2f7d16a05af74ebfb1ca42d0f9c3c3524692d | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.72e-04 | 170 | 40 | 3 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.72e-04 | 170 | 40 | 3 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass | 4.81e-04 | 171 | 40 | 3 | dcb6c41980008d0b9eeb54999faff77311554976 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 4.81e-04 | 171 | 40 | 3 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 4.89e-04 | 172 | 40 | 3 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | NS-critical-d_0-4-Epithelial-FOXN4+|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.89e-04 | 172 | 40 | 3 | a00bb44d33658cb3a98accd6b60f3ce964c425b4 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-04 | 173 | 40 | 3 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.97e-04 | 173 | 40 | 3 | 5295ed31648abf8edff214cf67cd4769f20f9e6d | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.06e-04 | 174 | 40 | 3 | 5e6050d20a5b27640f6a200441125b8ceba123c8 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-04 | 174 | 40 | 3 | 118ba2729ecc6aa1bb8548f3cf537b3f9e902ef0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-04 | 174 | 40 | 3 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 175 | 40 | 3 | 69b59ec58e64644deb7e07f31ef495ef4a6f6276 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 175 | 40 | 3 | c1a8a55af825d5913095f919fa860828df9c273e | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 175 | 40 | 3 | 510c46bfd250ef83fcad8f6b01efbcca9d71a9a2 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 175 | 40 | 3 | 78b453e220218c84557f244ef7a760e4a1952761 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 175 | 40 | 3 | 4f7498b5a0ed52c348a5f94bcd41d830ba7954ea | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-04 | 176 | 40 | 3 | eddac2ba68d234e3f56f4ca0e11c19bc0e95b6e1 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 177 | 40 | 3 | 8f0873d348f37c823294b698043319b6608b678a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.40e-04 | 178 | 40 | 3 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-04 | 178 | 40 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-04 | 178 | 40 | 3 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.49e-04 | 179 | 40 | 3 | bc95c3e7edc5fc6fc913b09f087d221df64c6f48 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-04 | 179 | 40 | 3 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-04 | 180 | 40 | 3 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-04 | 180 | 40 | 3 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-04 | 180 | 40 | 3 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.58e-04 | 180 | 40 | 3 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-04 | 181 | 40 | 3 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.76e-04 | 182 | 40 | 3 | f30e5a21b49f30b82e2b6f1fd2daefd805a40083 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.76e-04 | 182 | 40 | 3 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-04 | 182 | 40 | 3 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-MAIT|COVID-19_Severe / Disease group, lineage and cell class | 5.76e-04 | 182 | 40 | 3 | 19045db5c726c06ec6e4feb4311633c8164ddb3c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.76e-04 | 182 | 40 | 3 | 1444cdc4522a70a40d697ccadf54cf26d327ade0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.76e-04 | 182 | 40 | 3 | cccac9f85825f4e310b86e37ee6320769a670501 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.76e-04 | 182 | 40 | 3 | 49eced222e8f90c2b59bcc7d56b62c3e703fcce5 | |
| ToppCell | URO-Lymphocyte-T_NK-dnT|URO / Disease, Lineage and Cell Type | 5.76e-04 | 182 | 40 | 3 | f2b1c524301d0f2d1b69c46f3653fd53c21c3aa0 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.85e-04 | 183 | 40 | 3 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 5.85e-04 | 183 | 40 | 3 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 184 | 40 | 3 | 10706441e7695212f95689414f31e8082b5eaf0a | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.95e-04 | 184 | 40 | 3 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 184 | 40 | 3 | 4bb0976a75126ad2b3deb5d2229f0716fafe200e | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 6.04e-04 | 185 | 40 | 3 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 185 | 40 | 3 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.04e-04 | 185 | 40 | 3 | 68edb1bb03ed221d49e583123ca4de14252d7bc5 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 6.14e-04 | 186 | 40 | 3 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 186 | 40 | 3 | 393f00ea6b434d4c8854dd8070d176579b71cd3b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-04 | 186 | 40 | 3 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-04 | 187 | 40 | 3 | 5fae538de481367cf6d9a2d52190d77b99f6922c | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-04 | 187 | 40 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.23e-04 | 187 | 40 | 3 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.34e-06 | 50 | 21 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Tazarotene | 2.01e-08 | 4 | 40 | 3 | DB00799 | |
| Drug | Alitretinoin | 1.00e-07 | 6 | 40 | 3 | DB00523 | |
| Drug | Adapalene | 1.00e-07 | 6 | 40 | 3 | DB00210 | |
| Drug | Etretinate | 1.00e-07 | 6 | 40 | 3 | DB00926 | |
| Drug | Acitretin | 1.75e-07 | 7 | 40 | 3 | DB00459 | |
| Drug | HX 600 | 2.80e-07 | 8 | 40 | 3 | ctd:C104181 | |
| Drug | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid | 2.80e-07 | 8 | 40 | 3 | ctd:C064545 | |
| Drug | Adapalene | 2.80e-07 | 8 | 40 | 3 | ctd:D000068816 | |
| Drug | TTNN | 2.80e-07 | 8 | 40 | 3 | CID000135754 | |
| Drug | 4-((4-(4-ethylphenyl)-2,2-dimethyl-(2H)-thiochromen-6-yl)ethynyl)benzoic acid | 2.80e-07 | 8 | 40 | 3 | ctd:C121616 | |
| Drug | UVI 3003 | 8.21e-07 | 11 | 40 | 3 | ctd:C525131 | |
| Drug | 4-hydroxyretinoic acid | 1.09e-06 | 12 | 40 | 3 | ctd:C019429 | |
| Drug | Cd2665 | 1.42e-06 | 13 | 40 | 3 | CID000216241 | |
| Drug | AC1L1DMQ | 1.80e-06 | 14 | 40 | 3 | CID000002418 | |
| Drug | Ro 8-8717 | 3.01e-06 | 2 | 40 | 2 | CID006438148 | |
| Drug | 4-carboxyphenylretinamide | 3.01e-06 | 2 | 40 | 2 | CID006439748 | |
| Drug | Tamibarotene | 3.01e-06 | 2 | 40 | 2 | DB04942 | |
| Drug | HX600 | 4.02e-06 | 18 | 40 | 3 | CID000128016 | |
| Drug | 3,4-didehydroretinoic acid | 4.02e-06 | 18 | 40 | 3 | CID000447276 | |
| Drug | 4-(1H-imidazol-1-yl)retinoic acid | 4.02e-06 | 18 | 40 | 3 | ctd:C496751 | |
| Drug | adapalene | 7.56e-06 | 22 | 40 | 3 | CID000060164 | |
| Drug | AC1L32JQ | 8.68e-06 | 23 | 40 | 3 | CID000133319 | |
| Drug | AGN 190299 | 9.02e-06 | 3 | 40 | 2 | ctd:C090766 | |
| Drug | 3-((4,6-diphenoxy-1,3,5-triazin-2-yl)amino)benzoic acid | 9.02e-06 | 3 | 40 | 2 | ctd:C529372 | |
| Drug | AC1L2X6Z | 1.43e-05 | 27 | 40 | 3 | CID000130325 | |
| Drug | SRI 5898-21 | 1.80e-05 | 4 | 40 | 2 | CID006439757 | |
| Drug | AGN 193109 | 1.97e-05 | 30 | 40 | 3 | ctd:C096920 | |
| Drug | Ro 41-5253 | 1.97e-05 | 30 | 40 | 3 | ctd:C084904 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.10e-05 | 192 | 40 | 5 | 6986_DN | |
| Drug | AGN 193109 | 2.18e-05 | 31 | 40 | 3 | CID000177238 | |
| Drug | Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; HL60; HT_HG-U133A | 2.43e-05 | 198 | 40 | 5 | 3110_UP | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.49e-05 | 199 | 40 | 5 | 6209_DN | |
| Drug | CD367 | 2.64e-05 | 33 | 40 | 3 | CID000119342 | |
| Drug | Cd2366 | 3.00e-05 | 5 | 40 | 2 | CID006443796 | |
| Drug | Ro 41-5253 | 3.74e-05 | 37 | 40 | 3 | CID005312120 | |
| Drug | tazarotene | 4.74e-05 | 40 | 40 | 3 | CID000005381 | |
| Drug | 4-oxoretinoic acid | 4.91e-05 | 115 | 40 | 4 | ctd:C002202 | |
| Drug | Etretinate-d3 | 6.77e-05 | 45 | 40 | 3 | CID000003312 | |
| Drug | 2-naphthoic acid | 8.37e-05 | 8 | 40 | 2 | CID000007123 | |
| Drug | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | 9.87e-05 | 51 | 40 | 3 | ctd:C038864 | |
| Drug | retinyl methyl ether | 1.08e-04 | 9 | 40 | 2 | CID006436634 | |
| Drug | HX 630 | 1.34e-04 | 10 | 40 | 2 | ctd:C422175 | |
| Drug | 3,5-di-tert-butylchalcone 4'-carboxylic acid | 1.34e-04 | 10 | 40 | 2 | ctd:C054189 | |
| Drug | CEPC | 1.34e-04 | 10 | 40 | 2 | CID000011483 | |
| Drug | CK 6 | 1.45e-04 | 58 | 40 | 3 | CID000447960 | |
| Drug | tazarotene | 1.64e-04 | 11 | 40 | 2 | ctd:C086827 | |
| Drug | AC1L2E0P | 1.93e-04 | 307 | 40 | 5 | CID000019390 | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.27e-04 | 171 | 40 | 4 | 1000_DN | |
| Drug | tazarotenic acid | 2.32e-04 | 13 | 40 | 2 | CID000147525 | |
| Drug | Ro 13-6298 | 2.32e-04 | 13 | 40 | 2 | CID006437076 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.32e-04 | 172 | 40 | 4 | 2330_DN | |
| Drug | retinamide | 2.43e-04 | 69 | 40 | 3 | CID005370221 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.48e-04 | 175 | 40 | 4 | 6891_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.54e-04 | 176 | 40 | 4 | 981_DN | |
| Drug | 9-cis-acitretin | 2.64e-04 | 71 | 40 | 3 | CID000041317 | |
| Drug | AC1L1JIR | 2.75e-04 | 72 | 40 | 3 | CID000005058 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.88e-04 | 182 | 40 | 4 | 947_DN | |
| Drug | Androgen Antagonists | 3.11e-04 | 75 | 40 | 3 | ctd:D000726 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.33e-04 | 189 | 40 | 4 | 1006_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 3.33e-04 | 189 | 40 | 4 | 5203_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 3.33e-04 | 189 | 40 | 4 | 1643_DN | |
| Drug | Griseofulvin | 3.36e-04 | 77 | 40 | 3 | ctd:D006118 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.46e-04 | 191 | 40 | 4 | 998_DN | |
| Drug | AC1L1KPQ | 3.49e-04 | 78 | 40 | 3 | CID000005602 | |
| Drug | TAC 101 | 3.56e-04 | 16 | 40 | 2 | ctd:C112689 | |
| Drug | Zardaverine [101975-10-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.67e-04 | 194 | 40 | 4 | 7347_UP | |
| Drug | diclofenac sodium; Down 200; 10uM; MCF7; HG-U133A | 3.75e-04 | 195 | 40 | 4 | 333_DN | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; HL60; HT_HG-U133A | 3.75e-04 | 195 | 40 | 4 | 3038_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.75e-04 | 195 | 40 | 4 | 3800_UP | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.75e-04 | 195 | 40 | 4 | 953_DN | |
| Drug | A-74702 | 3.76e-04 | 80 | 40 | 3 | CID000452307 | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; PC3; HG-U133A | 3.82e-04 | 196 | 40 | 4 | 1929_UP | |
| Drug | Acemetacin [53164-05-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 3.82e-04 | 196 | 40 | 4 | 6361_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 3.82e-04 | 196 | 40 | 4 | 4100_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; PC3; HT_HG-U133A | 3.82e-04 | 196 | 40 | 4 | 7278_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.82e-04 | 196 | 40 | 4 | 4948_DN | |
| Drug | Sulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HG-U133A | 3.82e-04 | 196 | 40 | 4 | 1913_UP | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; HL60; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 2954_UP | |
| Drug | Brinzolamide [138890-62-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 5016_UP | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 4403_UP | |
| Drug | Epiandrosterone [481-29-8]; Up 200; 13.8uM; HL60; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 2444_UP | |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 2300_DN | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 1468_DN | |
| Drug | Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 3414_UP | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; HL60; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 6146_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; PC3; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 4292_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 6239_DN | |
| Drug | GW0072 | 4.03e-04 | 17 | 40 | 2 | CID000449532 | |
| Drug | protoporphyrin IX dimethyl ester | 4.03e-04 | 17 | 40 | 2 | CID000194637 | |
| Drug | enilconazole | 4.03e-04 | 17 | 40 | 2 | ctd:C017435 | |
| Drug | Trolox [53188-07-1]; Up 200; 16uM; MCF7; HT_HG-U133A | 4.05e-04 | 199 | 40 | 4 | 2883_UP | |
| Drug | Bumetanide [28395-03-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.05e-04 | 199 | 40 | 4 | 5542_UP | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 4.05e-04 | 199 | 40 | 4 | 4423_UP | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; HL60; HT_HG-U133A | 4.05e-04 | 199 | 40 | 4 | 6125_UP | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A | 4.05e-04 | 199 | 40 | 4 | 4543_DN | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; HL60; HT_HG-U133A | 4.05e-04 | 199 | 40 | 4 | 3079_DN | |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.12e-04 | 200 | 40 | 4 | 6837_UP | |
| Drug | CD437 | 4.36e-04 | 203 | 40 | 4 | CID000135411 | |
| Drug | SR11237 | 4.52e-04 | 18 | 40 | 2 | CID000127019 | |
| Drug | tamibarotene | 4.65e-04 | 86 | 40 | 3 | CID000108143 | |
| Disease | factor VIII measurement, Ischemic stroke | 2.04e-06 | 19 | 39 | 3 | EFO_0004630, HP_0002140 | |
| Disease | pain | 5.89e-06 | 196 | 39 | 5 | EFO_0003843 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 8.46e-06 | 30 | 39 | 3 | EFO_0004629, HP_0002140 | |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 1.02e-05 | 4 | 39 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 1.02e-05 | 4 | 39 | 2 | C0751925 | |
| Disease | Lesion of Sciatic Nerve | 1.02e-05 | 4 | 39 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 1.02e-05 | 4 | 39 | 2 | C0242013 | |
| Disease | Sciatic Neuropathy | 1.02e-05 | 4 | 39 | 2 | C0149940 | |
| Disease | Congenital muscular dystrophy (disorder) | 2.54e-05 | 6 | 39 | 2 | C0699743 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.84e-05 | 152 | 39 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | 6.76e-05 | 1074 | 39 | 8 | C0006142 | |
| Disease | serum urea measurement | 1.27e-04 | 195 | 39 | 4 | EFO_0009795 | |
| Disease | juvenile idiopathic arthritis | 1.30e-04 | 74 | 39 | 3 | EFO_0002609 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 1.77e-04 | 15 | 39 | 2 | EFO_0004791, HP_0002140 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 2.02e-04 | 16 | 39 | 2 | EFO_0004792, HP_0002140 | |
| Disease | factor XI measurement, Ischemic stroke | 2.29e-04 | 17 | 39 | 2 | EFO_0004694, HP_0002140 | |
| Disease | Intellectual Disability | 2.94e-04 | 447 | 39 | 5 | C3714756 | |
| Disease | Anophthalmia-microphthalmia syndrome | 3.52e-04 | 21 | 39 | 2 | cv:C5680330 | |
| Disease | Autistic Disorder | 3.86e-04 | 261 | 39 | 4 | C0004352 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 5.13e-04 | 118 | 39 | 3 | EFO_0001645, EFO_0004629 | |
| Disease | Ischemic stroke, factor VII measurement | 6.76e-04 | 29 | 39 | 2 | EFO_0004619, HP_0002140 | |
| Disease | Mental Retardation, Psychosocial | 8.26e-04 | 139 | 39 | 3 | C0025363 | |
| Disease | Profound Mental Retardation | 8.26e-04 | 139 | 39 | 3 | C0020796 | |
| Disease | Mental deficiency | 8.26e-04 | 139 | 39 | 3 | C0917816 | |
| Disease | unipolar depression | 9.14e-04 | 1206 | 39 | 7 | EFO_0003761 | |
| Disease | carbohydrate intake measurement | 9.30e-04 | 34 | 39 | 2 | EFO_0010811 | |
| Disease | urate measurement | 1.06e-03 | 895 | 39 | 6 | EFO_0004531 | |
| Disease | Craniofacial Abnormalities | 1.15e-03 | 156 | 39 | 3 | C0376634 | |
| Disease | migraine disorder | 1.24e-03 | 357 | 39 | 4 | MONDO_0005277 | |
| Disease | spleen volume | 1.49e-03 | 43 | 39 | 2 | EFO_0600047 | |
| Disease | blood phosphate measurement | 1.58e-03 | 174 | 39 | 3 | EFO_0010972 | |
| Disease | heart failure | 1.88e-03 | 185 | 39 | 3 | EFO_0003144 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTLYPPPPSPSFTTP | 1406 | Q9NR48 | |
| PPPPPPFTSYIVSTP | 256 | Q96EP5 | |
| ASYIPPSPPTPPVPV | 821 | Q70E73 | |
| YVPPPVPLPPGPSTH | 2221 | Q96L73 | |
| IVPSPPSPPPLPRIY | 71 | P10276 | |
| LVPSPPSPLPPPRVY | 71 | P10826 | |
| SSPSPPPPPRVYKPC | 76 | P13631 | |
| PVPPPQPLPTPYTYP | 911 | Q9H3S7 | |
| SPEPPPSPLQVPTYP | 571 | Q9HCH0 | |
| PTPTPAPVYDVPNPP | 636 | Q92823 | |
| PVPVSPGVQPLYPIP | 971 | Q99700 | |
| EPPVYVPPPSYRSPP | 336 | Q9P266 | |
| PEPVPTPAFPTPTPV | 2731 | P24043 | |
| PATPVFVPVPPPPLY | 551 | Q7Z6E9 | |
| SSPYPPLPPRPSASP | 1011 | Q9Y4H2 | |
| SPVPPVPGAPPTYIS | 536 | Q9Y6I3 | |
| PALPTGVPPVPTQYP | 396 | Q7Z7F0 | |
| PTGYRPPPPPPTQET | 251 | O75525 | |
| PPPPPPVYEPVSYHV | 471 | P15311 | |
| PAPTPLPAPAPPTAY | 236 | A6NMB9 | |
| PSGYPCLPPPPTVPL | 931 | Q5VV67 | |
| PSPAPPPYTPPTHVL | 546 | Q86YQ8 | |
| YPPSAHPPTLPPSAP | 326 | Q9H0F5 | |
| VPPVPPASSTPYKPP | 6476 | Q8WXH0 | |
| RPGFPPPTYVIPPPV | 661 | Q92540 | |
| TPPLPPYASPRSPPV | 266 | Q96ST3 | |
| AVPTPACPYAPPTPP | 256 | Q99697 | |
| PAQSLPASYTPPPPP | 266 | Q9Y2V3 | |
| PSPPPPSPTTYNCPK | 896 | Q9UPX8 | |
| PPPPTTSPPEPPYST | 921 | Q9Y566 | |
| TSPPEPPYSTPPVPS | 926 | Q9Y566 | |
| PTPTEPPPPYSFRPE | 131 | Q6UXU6 | |
| PPPPPPPTYRTVVSS | 411 | Q9BQI5 | |
| PPPSIEPLTPPPQYD | 226 | Q9NW97 | |
| EYPPPPPEPAATPTS | 521 | Q9P1Z0 | |
| SVIIFPPPPPPYFPE | 216 | Q8WVE6 | |
| PIQATPPPPPLPSQY | 1421 | Q07157 | |
| PPYPLPYSPSPSLPV | 201 | A5D8V6 | |
| PPIYPTSPGPIPITL | 1331 | Q6BDS2 | |
| TPPPPYTVAPGRPLT | 136 | Q96G27 | |
| TGYTVPPARPPPPLT | 371 | Q5VZL5 | |
| PRLPSYPPPPPTVGL | 16 | Q6SJ96 |